The Institute for Advancing Medical Innovation, established at the University of Kansas with funding from the Ewing Marion Kauffman Foundation, focuses on education and research that advances medical innovations, ultimately accelerating the number and quality of new drugs, medical devices, and drug–medical device combinations from the bench to the bedside.
- Led or assisted in managing the pathway of seven drugs to clinical trials in three years
- Manages the link between investigators, physicians, and patients
The Institute for Advancing Medical Innovation serves as a national model for philanthropy, industry, and universities to collaborate in advancing university innovations in life sciences by:
- Focusing on research and developments that advance novel drug therapies and medical device innovations to patients through partnerships and collaborations
- Providing funding for innovations, discovery, and development of new drugs therapies and medical devices to patients